339 related articles for article (PubMed ID: 3760120)
1. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic evaluation of hirsutism in women.
Farber M; Millan VG; Turksoy RN; Mitchell GW
Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
[TBL] [Abstract][Full Text] [Related]
5. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
Wajchenberg BL; Achando SS; Mathor MM; Czeresnia CE; Giannella Neto D; Kirschner MA
Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
[TBL] [Abstract][Full Text] [Related]
6. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
7. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
8. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
Bardin CW; Hembree WC; Lipsett MB
J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
[No Abstract] [Full Text] [Related]
9. Idiopathic hirsutism--an ovarian abnormality.
Kirschner MA; Zucker IR; Jespersen D
N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
[TBL] [Abstract][Full Text] [Related]
10. Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women.
Kirschner MA; Jacobs JB
J Clin Endocrinol Metab; 1971 Aug; 33(2):199-209. PubMed ID: 4935635
[No Abstract] [Full Text] [Related]
11. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
12. The origin of androgen synthesis in polycystic ovary syndrome.
Milewicz A; Silber D; Mielecki T
Obstet Gynecol; 1983 Nov; 62(5):601-4. PubMed ID: 6225965
[TBL] [Abstract][Full Text] [Related]
13. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
14. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
15. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
16. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
Abraham GE; Maroulis GB; Buster JE; Chang RJ; Marshall JR
Obstet Gynecol; 1976 Apr; 47(4):395-402. PubMed ID: 130572
[TBL] [Abstract][Full Text] [Related]
18. Androgen and estrogen formation in women with ovarian hyperthecosis.
Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
[TBL] [Abstract][Full Text] [Related]
19. Adrenal abnormalities in polycystic ovary syndrome.
Loughlin T; Cunningham S; Moore A; Culliton M; Smyth PP; McKenna TJ
J Clin Endocrinol Metab; 1986 Jan; 62(1):142-7. PubMed ID: 3079598
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.
Fulghesu AM; Lanzone A; Fortini A; Guido M; Caruso A; Mancuso S
J Reprod Med; 1993 May; 38(5):387-92. PubMed ID: 8320677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
